Belabumbum, a line of ethically sourced loungewear & intimates made specially for mothers, has announced a new collaboration with fellow Adore Me sister brand Joyja. Joyja creates eco-friendly period panties. Together the brands are now launching a line of leak-proof underwear and ultra-absorbent nursing pads. According to reports, one in three women experience fluid releases during pregnancy and after birth for a variety…
Bayer has announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that extends the duration of use for its intrauterine device (IUD) Mirena (levonorgestrel-releasing intrauterine system) 52 mg by one year, making it available to prevent pregnancy for up to seven years. The approval is based on results from a Phase 3 extension trial evaluating the…
Medical Cannabis Company Tikun Olam Cannbit has reportedly entered a new partnership with Israel-based femtech company Gynica. Gynica develops cannabinoid-based solutions for women’s health. Tikun Olam-Cannbit announced an “estimated NIS 5 million [approximately $1.5M] agreement for investment in 20% of the shares in Gynica.” In exchange for the allocated shares, Tikun Olam-Cannbit will provide Gynica with an array of services for development of vaginal suppositories, lubricating gel…
Black women are 3-4x more likely to die of pregnancy related causes than white women, yet more than 60% of pregnancy related death could have been prevented. Black babies are two times more likely to die a premature death compared to white babies. Today, the US has one of the highest rates of maternal mortality in the developing world. Black women are…
It’s that time of the year again… Y Combinator Demo Day. And as always we had a look through the 300+ companies, that were part of the most recent batch (S21) to see if any of them are active in the women’s health space. And indeed we found a few femtech startups, that are getting ready to pitch this week! Below is an…
Visby Medical has received a 510(k) clearance and was granted a waiver under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) from the US Food and Drug Administration (FDA) to market its fast, single-use polymerase chain reaction (PCR) diagnostic test for the multiplexed detection of sexually transmitted infections (STIs) caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV), using a self-collected vaginal swab. With the…
Swiftarc Ventues has announces a new §10M fund to invest in female-founded beauty and wellness companies. Swiftarc was founded by Sid Jawahar in 2019; this is the VCs fourth fund. In a recent interview with Techcrunch he explains: “The beauty industry in stuck in time where 75% to 80% of sales are still made from wholesale. E-commerce and digitally native brands are…
Roche has decided to withdraw its immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States. The drug received accelerated approval in 2019 to treat inoperable, locally advanced or metastatic triple-negative breast cancer (mTNBC) in people whose tumors express PD-L1, a protein that may help the cancer avoid detection by the immune system. But it failed last year…
